In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4332-4337

  Cucco, Carla ^a,b   Calabretta, Bruno ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GENE PRODUCT; GLYCOPROTEIN P; VINCRISTINE; VINCRISTINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SEQUENCE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; VINCRISTINE;

EID: 0029740475     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Goldstein, L J., Galski, H., Fojo, A., Willingham, M., Lai, A., Gazdar, A, Pirker, R., Green, A., Crist, W., Brodeur, G. M, Lieber, M., Cossman, J, Gottesman, M M., and Pastan, I. Expression of multidrug resistance gene in human cancers J. Natl. Cancer Inst., 81: 116-124, 1989.
2. Roninson, I. B. The role of MDR-1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol, 43: 95-102, 1992
3. Christensen, J G., and LeBlanc, G. A. Reversal of multidrug resistance in vivo by dietary administration of the photochemical indole-3-carbinol. Cancer Res., 56: 574-581, 1996
4. Gottesman, M M., and Pastan, I Biochemistry of multidrug resistance mediated by the multidrug transporter Annu. Rev Biochem., 62: 385-427, 1993.
5. Ford, J. M., and Hait, W. M. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42 155-199, 1990.
6. Héléne, C., and Toulmé, J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys. Acta, 1049(2): 99-125, 1990.
7. Calabretta, B. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Cancer Res., 51: 4505-4510, 1991.
8. Wagner, R W. Gene inhibition using antisense oligodeoxynucleotides Nature (Lond), 372: 333-335, 1994
9. Jaroszewski, J. W, Kaplan, O, Syi, J-L, Sehested, M. Faustino, P. J, and Cohen, J. S. Concerning antisense inhibition of the multiple drug resistance gene. Cancer Commun., 2: 287-294, 1990.
10. Quattrone, A, Papucci, L, Morganti, M, Coronnello, M. Mini, E., Mazzei, T, Colonna, F, P, Garbesi, A, and Capaccioli, S Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. Oncol Res., 6: 311-320, 1994.
11. Thierry, A R, Rahman, A., and Dntschilo, A. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem. Biophys Res. Commun, 190: 952-960, 1993.
12. Kamel-Reid, S, Letarte, M., Sirard, C., Doedens, M., Grunberger, T., Fulop, G., Freedman, M. H., Phillips, R. A., and Dick, J. E. A model of human acute lymphobastic leukemia in immune-deficient SCID mice. Science (Washington DC), 246: 1597-1600, 1989.
13. Krishnamachary, N, and Center, M. S. The MRP gene associated with non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein Cancer Res., 53: 3658-3661, 1993.
14. Chen. C-J., Chin, J. E, Ueda, K., Clark, D. P., Pastan, I, Gottesman, M. M., and Roninson, I B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47: 381-389, 1986.
15. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal. Biochem, 162: 156-159, 1987.
16. Del Bufalo, D., Cucco, C., Leonetti, C., Citro, G., D'Agnano, I., Benassi, M., Geiser, T., Zon, G., Calabretta, B., and Zupi, G. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo Br. J. Cancer, 74(3): 387-393, 1996.
17. Noonan, K. E, Beck, C., Holzmayer, T. A, Chin, J. E., Wunder, J S., Andrulis, I L., Gazdar, A. F., Williman, C. L, Griffith, B. Van Hoff, D D., and Roninson, I. B Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci USA, 87: 7160-7164, 1990.
18. Ratajczak, M. Z., Kant, J A, Luger, S. M., Hijiya, N., Zhang, J., Zone G., and Gewirtz, A. M In vivo treatment of human leukemia in a SCID mouse model with c-myb antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA, 89, 11823-11827, 1992
19. Agrawal, S, Temsamani, J, and Tang, J-Y. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad Sci. USA, 88, 7595-7599, 1991.
20. Stein, C. A., Subasinghe, C., Shinozuka, K., and Cohen, J. S Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res., 16: 3209-3221, 1988.
21. Richert, N D, Aldwin, L., Nitecki, D., Gottesman, M. M, and Pastan, I Stability and covalent modification of P-glycoprotein in multi-drug-resistant KB cells. Biochemistry, 27: 7607-7613, 1988
22. Corrias, M V., and Tonini, G P. An oligomer complementary to the 5′ end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res., 12: 1431-1438, 1992.
23. Brown, D. A., Kang, S-H., Gryaznov, S. H., DeDionisio, L., Heidenreich, D., Sullivan, S, Xu, X, and Nerenberg, M I Effect of phosphorothioate modification of oligodeoxynucleotide on specific protein binding. J Biol Chem., 269: 26801-26805, 1994.
24. Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J L, and Stein, C. Y Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors and remove it from low efficiency binding sites on extracellular matrix. J. Biol. Chem, 270: 2620-2627, 1995.